pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Interchangeability of Arterial Coagulation and Venous Coagulation, in the Context of Cardiac Surgeries Under Cardiopulmonary Bypass, Using the DMDiv Hemochron Signature Elite
Status: RECRUITING
Conditions: Hemostasis|Extracorporeal Circulation|Heparin|Cardio-pulmonary Bypass
Interventions: PROCEDURE: interchangeability of arterial or venous hemostasis
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection
Status: UNKNOWN
Conditions: AIDS/HIV PROBLEM
Interventions: DRUG: Triplitode|DRUG: Tenofovir plus lamivudine plus Lopinavir / ritonavir plus raltegravir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
Status: COMPLETED
Conditions: Diabetes Mellitus Type II
Interventions: DRUG: Liraglutide|DRUG: Insulin bolus|DRUG: GIK infusion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections
Status: COMPLETED
Conditions: Infections
Interventions: DRUG: Daptomycin|DRUG: Vancomycin or Semi-Synthetic Penicillins (SSPs)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: "InDACtion" vs "3+7" Induction in AML
Status: ACTIVE_NOT_RECRUITING
Conditions: Acute Myeloid Leukemia (AML)
Interventions: DRUG: standard combination chemotherapy|DRUG: decitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease
Status: COMPLETED
Conditions: Urinary Tract Disease
Interventions: DEVICE: LithoVue Ureteroscope System
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture
Status: COMPLETED
Conditions: Forearm Fracture
Interventions: DRUG: Ibuprofen|DRUG: Ibuprofen|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Early Mobilization After Achilles Tendon Rupture
Status: ACTIVE_NOT_RECRUITING
Conditions: Achilles Tendon Rupture|Deep Venous Thrombosis
Interventions: DEVICE: VACOped orthosis|DEVICE: Plaster cast
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Venlafaxine on Language Function in Patients With Subcortical Aphasia: A fMRI Study
Status: COMPLETED
Conditions: Subcortical Aphasia|Ischemic Stroke
Interventions: DRUG: Venlafaxine hydrochloride capsules
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Status: RECRUITING
Conditions: Non Hodgkin Lymphoma|Richter Transformation|Multiple Myeloma|T-cell-prolymphocytic Leukemia|Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Myeodysplastic Syndrome|Myelodysplastic/Myeloproliferative Neoplasm|Myelofibrosis|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Chronic Myelomonocytic Leukemia-2|Myelodysplastic Neoplasm in Blast Phase
Interventions: DRUG: LP-118
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.
Status: COMPLETED
Conditions: Vestibular Schwannoma
Interventions: RADIATION: gamma knife radiosurgery
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients
Status: COMPLETED
Conditions: Atopic Dermatitis
Interventions: DRUG: Ciclosporin|DRUG: Methotrexate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate Central Nervous System (CNS) Pharmacodynamic Activity of TAK-653 in Healthy Participants Using Transcranial Magnetic Stimulation (TMS)
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: TAK-653|DRUG: Placebo|DRUG: Ketamine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma
Status: COMPLETED
Conditions: Carcinoma, Renal Cell|Clear-cell Metastatic Renal Cell Carcinoma
Interventions: BIOLOGICAL: Nivolumab/Ipilimumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy
Status: COMPLETED
Conditions: Remote Ischaemic Preconditioning|Contrast Induced Nephropathy
Interventions: OTHER: RIPC
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Macitentan|DRUG: Sildenafil|DRUG: Riociguat|DRUG: Rosuvastatin
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy
Status: COMPLETED
Conditions: Pain Relief During Prostate Biopsy
Interventions: DRUG: Diazepam|DRUG: Lidocaine 1%|DRUG: Diazepam and Lidocaine 1%
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Status: NOT_YET_RECRUITING
Conditions: HPV-Associated Cervical Carcinoma|HPV-Related Carcinoma|HPV-Related Malignancy|HPV Positive Oropharyngeal Squamous Cell Carcinoma|HPV-Related Adenocarcinoma|HPV-Related Adenosquamous Carcinoma|HPV-Related Squamous Cell Carcinoma|HPV-Related Anal Squamous Cell Carcinoma|HPV-Related Penile Squamous Cell Carcinoma|HPV-Related Vulvar Squamous Cell Carcinoma|HPV-Related Endocervical Adenocarcinoma|Cervical Cancer|Oropharynx Cancer|Anal Cancer|Vulvar Cancer|Penile Cancer|Vaginal Cancer
Interventions: BIOLOGICAL: E7 TCR-T cells|DRUG: Aldesleukin
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections
Status: TERMINATED
Conditions: Infection; Dialysis Catheter
Interventions: DRUG: NAC/Tigecycline/Heparin combination lock solution|DRUG: Standard anticoagulant (Heparin or Citrate)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Performance Evaluation of Two Silicone Hydrogel Toric Lens Designs in Habitual Soft Contact Lens Wearers
Status: COMPLETED
Conditions: Astigmatism
Interventions: DEVICE: Lens A (comfilcon A toric lens)|DEVICE: Lens B (lehfilcon A toric lens)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Mantle Cell Lymphoma
Interventions: DRUG: Cyclophosphamide|DRUG: Cytarabine|DRUG: Dexamethasone|DRUG: Doxorubicin Hydrochloride|DRUG: Ibrutinib|DRUG: Methotrexate|BIOLOGICAL: Rituximab|DRUG: Venetoclax|DRUG: Vincristine Sulfate
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol
Status: TERMINATED
Conditions: Clostridium Difficile
Interventions: DRUG: Misoprostol 100Mcg Tab|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram
Status: COMPLETED
Conditions: Dosimetry|Healthy
Interventions: DRUG: [C-11](R)-rolipram
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer
Status: COMPLETED
Conditions: Advanced Gastric Cancer
Interventions: DRUG: Pazopanib|DRUG: 5-FU, Oxaliplatin, Leukovorin (FLO)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Prospective Multicenter Cohort Study About Internal Fixation Using FNS Versus MCS for Femoral Neck Fracture
Status: RECRUITING
Conditions: Femoral Neck Fractures
Interventions: DEVICE: FNS|DEVICE: MCS
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
Status: COMPLETED
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Interventions: BIOLOGICAL: efgartigimod PH20 SC in stage B|OTHER: placebo in stage B
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
Status: COMPLETED
Conditions: Multiple Sclerosis
Interventions: DRUG: Atorvastatin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)
Status: TERMINATED
Conditions: Allergic Fungal Rhinosinusitis
Interventions: DRUG: Dupilumab|DRUG: Placebo|DRUG: Intranasal Corticosteroid Sprays (INCS)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Lithium in Multiple System Atrophy
Status: TERMINATED
Conditions: Multiple System Atrophy
Interventions: DRUG: Lithium Carbonate|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Comparison of Laparoscopic to Vaginal Surgical Repair for Uterine Prolapse
Status: TERMINATED
Conditions: Uterine Prolapse
Interventions: PROCEDURE: Laparoscopic supracervical hysterectomy with sacropexy|PROCEDURE: Vaginal hysterectomy with uterosacral colposuspension
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
Status: COMPLETED
Conditions: Atrial Fibrillation
Interventions: DRUG: Valsartan|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Assessment of the Impact of Early Treatment for Anorexia Nervosa in a Day Hospital on Food Symptomatology, the Outcome of Young Patients, and the Family Experience
Status: RECRUITING
Conditions: Anorexia Nervosa
Interventions: OTHER: Day Hospital Treatment|OTHER: Multidisciplinary follow-up "as usual" within the service|OTHER: Conduct semi-structured qualitative interviews
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Pre-Op Sildosine and Ureteral Dilation During F-URS
Status: COMPLETED
Conditions: FURS|Ureteral Dilatation|Sildosine
Interventions: DRUG: Sildosin group|PROCEDURE: Placebo/control group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Serratus Anterior Plane Block Versus Intercostal Nerve Block for Postoperative Analgesia
Status: UNKNOWN
Conditions: Analgesia|Postoperative Pain|Lung Cancer
Interventions: PROCEDURE: Thoracoscopic lobectomy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis
Status: WITHDRAWN
Conditions: Knee Osteoarthritis
Interventions: BIOLOGICAL: Human allogeneic mesenchymal bone marrow derived stem cells
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)
Status: COMPLETED
Conditions: Pneumococcal Infections
Interventions: BIOLOGICAL: V114 Lot 1|BIOLOGICAL: V114 Lot 2|BIOLOGICAL: Prevnar 13™
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR
Status: NOT_YET_RECRUITING
Conditions: AML, Adult
Interventions: DRUG: Decitabine|DRUG: Fludarabine Injection|DRUG: Busulfan Injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma
Status: UNKNOWN
Conditions: Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Interventions: DRUG: LEAP regimen
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Spherical Aberration and Contrast Sensitivity Function in Eyes Implanted With Spherical and Aspheric Intraocular Lenses: A Clinical Trial
Status: COMPLETED
Conditions: Cataract
Interventions: DEVICE: Intraocular lens|DEVICE: Intraocular lens|DEVICE: Intraocular lens
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose:
Clinical trial: Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma
Status: COMPLETED
Conditions: Brain and Central Nervous System Tumors
Interventions: BIOLOGICAL: cintredekin besudotox|PROCEDURE: adjuvant therapy|PROCEDURE: conventional surgery|PROCEDURE: neoadjuvant therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: The Wrist-Free Study - Comparing Traditional Above Elbow Casts to Ones That Free the Wrist
Status: RECRUITING
Conditions: Supracondylar Humerus Fracture
Interventions: PROCEDURE: Modified long arm cast|PROCEDURE: Traditional long arm cast
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Proprioceptive Sensitivity Stimulation Via the SURA Electrodevice on Kinematics, Kinetics and Spatiotemporal Parameters of Gait.
Status: NOT_YET_RECRUITING
Conditions: Stroke
Interventions: DEVICE: SURA
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers
Status: COMPLETED
Conditions: Healthy Adult Volunteers
Interventions: BIOLOGICAL: Activated charcoal and Tap Water|BIOLOGICAL: Activated Charcoal and Apple Juice
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients
Status: COMPLETED
Conditions: Hepatitis C Virus
Interventions: DRUG: Sofosbuvir|DRUG: Placebo to match sofosbuvir|DRUG: PEG|DRUG: RBV
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients
Status: WITHDRAWN
Conditions: Prostate Cancer Metastatic|Castrate Resistant Prostate Cancer|Metastatic Prostate Cancer|Metastatic Prostate Adenocarcinoma
Interventions: OTHER: High Intensity Interval Training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients
Status: COMPLETED
Conditions: Ovarian Neoplasms
Interventions: DRUG: taxol
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Transcutaneous Auricular Neurostimulation After Lumbar Fusion Surgery
Status: NOT_YET_RECRUITING
Conditions: Pain, Postoperative|Opioid Use|Lumbar Spine Injury
Interventions: DEVICE: Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN)|DEVICE: Sham Control Device
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
Status: UNKNOWN
Conditions: Head and Neck Cancer
Interventions: BIOLOGICAL: autologous Epstein-Barr virus-specific cytotoxic T lymphocytes|DRUG: carboplatin|DRUG: gemcitabine hydrochloride|GENETIC: polymerase chain reaction|OTHER: fluorescence activated cell sorting|OTHER: immunoenzyme technique
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma
Status: UNKNOWN
Conditions: Peripheral T Cell Lymphoma
Interventions: DRUG: Bortezomib|DRUG: Etoposide|DRUG: Cyclophosphamide|DRUG: Pharmorubicin|DRUG: Prednisone
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparing Intra-articular Corticosteroid to Intra-articular Ketorolac Knee Injections
Status: UNKNOWN
Conditions: Knee Osteoarthritis
Interventions: DRUG: Ketorolac|DRUG: Betamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
Clinical trial: Study of Low Field Magnetic Stimulation (LFMS) on Measures of Sleep
Status: TERMINATED
Conditions: Insomnia, Primary
Interventions: DEVICE: LFMS - Active|DEVICE: LFMS - Sham
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse
Status: COMPLETED
Conditions: Major Depressive Disorder|Recurrent
Interventions: BEHAVIORAL: Mindfulness Based Cognitive Therapy|BEHAVIORAL: Health Enhancement Program
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Conus Medullaris Stimulation With 5 Columns Lead Versus Medical Treatment in Refractory Pudendal Neuralgia
Status: COMPLETED
Conditions: Pudendal Neuralgia
Interventions: DEVICE: CMS group|OTHER: OMM group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: L-citrulline Injection in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting With Vaso-Occlusive Crisis (VOC)
Status: RECRUITING
Conditions: Acute Vaso Occlusive Crisis (VOC)
Interventions: DRUG: L-citrulline|OTHER: D5 1/2NS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Maternal BMI and Type of Infants Feeding on IGF-1 in Infant
Status: UNKNOWN
Conditions: IGF1 Deficiency
Interventions: DIAGNOSTIC_TEST: level of IGF-1 in infants
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SCREENING
Clinical trial: Cardiac Cath Lab Staff Radiation Exposure
Status: TERMINATED
Conditions: Coronary Artery Disease|Chronic Total Occlusion of Coronary Artery|Percutaneous Coronary Intervention
Interventions: DEVICE: Robotic CTO PCI|PROCEDURE: Conventional (Manual) CTO PCI
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer
Status: RECRUITING
Conditions: Colorectal Carcinoma
Interventions: OTHER: endurance exercise|OTHER: control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15
Status: COMPLETED
Conditions: Acute Pain
Interventions: DRUG: DFN-15 (Celecoxib Oral Solution) 62.5 mg|DRUG: DFN-15 (Celecoxib Oral Solution) 125 mg|DRUG: DFN-15 (Celecoxib Oral Solution) 250 mg|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms
Status: COMPLETED
Conditions: Alzheimer's Disease
Interventions: DRUG: S47445 5mg|DRUG: S47445 15mg|DRUG: S47445 50mg|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli
Status: COMPLETED
Conditions: Neurocognitive Dysfunction
Interventions: PROCEDURE: Transseptal Aortic Approach Catheter Ablation Procedure|PROCEDURE: Retrograde Aortic Approach Catheter Ablation Procedure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Functional Ingredients: Effect in Gastrointestinal System
Status: COMPLETED
Conditions: Overweight|Diabetes|Constipation
Interventions: DIETARY_SUPPLEMENT: Ready-to-eat frozen soups added unripe banana flour|DIETARY_SUPPLEMENT: Ready-to-eat frozen soups added maltodextrin|DIETARY_SUPPLEMENT: Ready-to-eat frozen soups added inulin|DIETARY_SUPPLEMENT: Ready-to-eat frozen soups added nisin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried
Status: UNKNOWN
Conditions: Haemophilus Influenzae Type b Infections
Interventions: BIOLOGICAL: Minhai-HIB|BIOLOGICAL: Act-HIB®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Stop Community MRSA Colonization Among Patients
Status: COMPLETED
Conditions: MRSA
Interventions: DRUG: Chlorhexidine gluconate soap|DRUG: Chlorhexidine gluconate oral rinse|DRUG: Mupirocin calcium 2 % ointment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)
Status: WITHDRAWN
Conditions: Rheumatoid Arthritis
Interventions: DRUG: etanercept|DRUG: infliximab|DRUG: adalimumab
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Early Intracordal Hyaluronic Acid Injection During Spontaneous Reinnervation for Unilateral Recurrent Laryngeal Nerve Paralysis
Status: COMPLETED
Conditions: Paralysis, Unilateral, Vocal Cord
Interventions: PROCEDURE: Intracordal hyaluronate injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Short-term Efficacy of Antidepressant in Patients Underwent TKA
Status: UNKNOWN
Conditions: Osteoarthritis Of Knee
Interventions: DRUG: Duloxetine Hydrochloride
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)
Status: TERMINATED
Conditions: Hypertension
Interventions: DRUG: valsartan|DRUG: pravastatin|DRUG: simvastatin|DRUG: ezetimibe (+) simvastatin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions
Status: ACTIVE_NOT_RECRUITING
Conditions: Prostate Cancer
Interventions: DIAGNOSTIC_TEST: Multiparametric magnetic resonance imaging (mpMRI)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins
Status: COMPLETED
Conditions: Inflammation|Blood Pressure|Platelet Function|Endothelial Function
Interventions: DRUG: omega-3|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children
Status: COMPLETED
Conditions: Obesity|Overweight
Interventions: DIETARY_SUPPLEMENT: Glucomannan|DIETARY_SUPPLEMENT: Maltodextrin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices
Status: COMPLETED
Conditions: Attention Deficit Hyperactivity Disorder
Interventions: DEVICE: Groundskeeper game for controls|DEVICE: Groundskeeper game for ADHD
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING
Clinical trial: Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma
Status: TERMINATED
Conditions: Ovarian Neoplasms
Interventions: DRUG: oregovomab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
Status: UNKNOWN
Conditions: Premenopause|Iron-deficiency|Iron Adverse Reaction|Iron Deficiency Anemia|Heavy Menstrual Bleeding
Interventions: DIETARY_SUPPLEMENT: Ferrous sulfate 14mg once daily|DIETARY_SUPPLEMENT: Ferrous sulfate 25mg once daily|DIETARY_SUPPLEMENT: Ferrous sulfate 25mg twice daily
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients
Status: WITHDRAWN
Conditions: Breast Carcinoma|Head and Neck Carcinoma|Radiation-Induced Dermatitis
Interventions: DRUG: Calendula Ointment|OTHER: Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment|OTHER: Polyethylene Glycol Hydrogel|DRUG: Silicone-based Film Forming Topical Gel|DRUG: Silver Sulfadiazine|DRUG: Topical Hydrocortisone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Promote Access to Stop Suicide: Comparison of Follow up Services for Youth at Risk for Suicide
Status: COMPLETED
Conditions: Suicide|Depressive Disorder, Major|Anxiety Disorders|Suicidal Ideation|Suicidal Impulses
Interventions: BEHAVIORAL: Standard of Care|BEHAVIORAL: Crisis Intervention|BEHAVIORAL: Wraparound Services
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Bioequivalence Study of CJ-30061 in Healthy Male Volunteers
Status: COMPLETED
Conditions: Hypertension|Hyperlipidemia
Interventions: DRUG: CJ-30061|DRUG: Exforge® 5/160mg & Lipitor® 20mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Does Local Cooling of Testis in Patients With Epididymitis Relieve Pain and Reduce Quantity of Analgetics Intake?
Status: UNKNOWN
Conditions: Pain
Interventions: OTHER: Local hypothermia|OTHER: Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Whole-Body Cooling for Birth Asphyxia in Term Infants
Status: COMPLETED
Conditions: Infant, Newborn|Hypoxia-Ischemia, Brain
Interventions: DEVICE: Induced hypothermia|DEVICE: Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Bone Mineral Density and Bone Metabolism in Older Women
Status: COMPLETED
Conditions: Osteoporosis, Age-Related
Interventions: OTHER: Resistance training|OTHER: Yijinjing|OTHER: Baduanjing|OTHER: Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Olmesartan in Essential Hypertension
Status: COMPLETED
Conditions: Essential Hypertension
Interventions: OTHER: placebo|DRUG: olmesartan medoxomil|DRUG: olmesartan medoxomil oral tablets, hydrochlorothiazide oral tablets
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis
Status: COMPLETED
Conditions: Coronary Atherosclerosis|Angina Pectoris|Myocardial Infarction
Interventions: DEVICE: Percutaneous coronary intervention (PCI)|DEVICE: Percutaneous coronary intervention (PCI)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety Study of Electroacupuncture for Simple Female Stress Urinary incontinence-a Multicenter Trial
Status: COMPLETED
Conditions: Urinary Stress Incontinence
Interventions: DEVICE: electroacupuncture group|DEVICE: sham electroacupuncture group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
Status: RECRUITING
Conditions: Urinary Retention Postoperative
Interventions: DRUG: Tamsulosin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
Clinical trial: Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
Status: COMPLETED
Conditions: Childhood Burkitt Lymphoma|Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Spinal Cord Neoplasm|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Brain Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma|Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: DRUG: ispinesib|OTHER: laboratory biomarker analysis|OTHER: pharmacological study
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)
Status: COMPLETED
Conditions: Amyotrophic Lateral Sclerosis (ALS)
Interventions: DRUG: Olanzapine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Bupropion for Smoking Cessation in Pregnancy
Status: COMPLETED
Conditions: Smoking Cessation|Pregnancy
Interventions: DRUG: Bupropion SR|DRUG: placebo|BEHAVIORAL: smoking cessation counseling
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study Comparing Tutomesh® Repair to Conventional Surgical Techniques in Potentially Contaminated Hernia Repair and Abdominal Wall Reconstruction
Status: COMPLETED
Conditions: Potentially Contaminated Hernia Repair|Potentially Contaminated Abdominal Wall Reconstruction
Interventions: PROCEDURE: Conventional technique|PROCEDURE: Technique Tutomesh®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Quality-of-Life-and-Cognitive-Oriented Rehabilitation Through the NeuronUP in Alzheimer's Disease
Status: COMPLETED
Conditions: Alzheimer Disease|Occupational Therapy|Quality of Life|Cognitive Impairment|Older People
Interventions: PROCEDURE: Conventional occupational therapy sessions + NeuronUP|PROCEDURE: Conventional occupational therapy sessions
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of High-dose Leukocytapheresis Using a Large Filter in Refractory Asthma
Status: COMPLETED
Conditions: Bronchial Asthma
Interventions: PROCEDURE: Leukocytapheresis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Infant Modified Constraint Induced Movement Therapy Paired With Neuromuscular Electrical Stimulation: a Case Series
Status: COMPLETED
Conditions: Hemiplegia|Cerebral Palsy|Unilateral Cerebral Palsy
Interventions: DEVICE: Neuromuscular electrical stimulation|BEHAVIORAL: Modified constraint induced movement therapy|BEHAVIORAL: Standard care for infant with asymmetrical hand function
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Generation of Organotypic Liver Cultures for the Identification of Biomarkers for the Prevention and Treatment of Liver Fibrosis
Status: RECRUITING
Conditions: Hepatic Fibrosis
Interventions: DIAGNOSTIC_TEST: Biopsy from patients undergoing surgery abdominal.
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms
Status: COMPLETED
Conditions: Schizophrenia and Predominant Negative Symptoms
Interventions: DRUG: SPD489 (lisdexamfetamine dimesylate)|DRUG: Placebo matching SPD489 (lisdexamfetamine dimesylate)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Upper Limb Intensive Therapies in Babies With Unilateral Cerebral Palsy.
Status: UNKNOWN
Conditions: Infantile Hemiplegia|Upper Extremity Paresis|Family|Constraint Induced Movement Therapy|Bimanual Intensive Therapy
Interventions: OTHER: Infant BIT|OTHER: Infant CIMT/BIT|OTHER: Conventional therapy|OTHER: infant cimt
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Developing and Testing a Small Private Online Course (SPOC) for Nurse-patient Communication About Sex.
Status: COMPLETED
Conditions: Nurse-Patient Relations
Interventions: BEHAVIORAL: Received the Nightingale in Gen-sEx course
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: Combining Shockwave Therapy and Platelet Rich Plasma to Treat Erectile Dysfunction in Diabetic Men (COCKTAIL-DM)
Status: TERMINATED
Conditions: Erectile Dysfunction With Diabetes Mellitus
Interventions: DEVICE: Shockwave Therapy (SWT)|DRUG: Autologous Platelet-Rich Plasma (PRP)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
Status: NOT_YET_RECRUITING
Conditions: Ovarian Cancer|High Grade Serous Adenocarcinoma of Ovary|Primary Peritoneal Carcinoma|Fallopian Tube Cancer
Interventions: DRUG: Fluzoparib|DRUG: Fluzoparib+Apatinib
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Breathing Exercises With And Without Aerobic Training In Patients With Postural Orthostatic Tachycardia Syndrome
Status: COMPLETED
Conditions: Postural Orthostatic Tachycardia Syndrome
Interventions: OTHER: Aerobic Training|OTHER: Conventional Treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma
Status: NOT_YET_RECRUITING
Conditions: Hepatocellular Carcinoma
Interventions: DRUG: Donafenib|DRUG: Sintilimab|OTHER: HAIC
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: 3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women
Status: COMPLETED
Conditions: Osteoporosis|Osteoporosis, Postmenopausal
Interventions: DRUG: Parathyroid Hormone-related Protein|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Comparison of Two Different Analgesic Regional Block Techniques in Pediatric Patients Undergoing a Hernia Repair
Status: RECRUITING
Conditions: Post Operative Pain|Inguinal Hernia
Interventions: PROCEDURE: Erector Spinae Plane Block|PROCEDURE: Caudal Block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus
Status: UNKNOWN
Conditions: Diabetic Complication
Interventions: DRUG: YJP-14
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD
Status: COMPLETED
Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: DRUG: FF/UMEC/VI
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer
Status: COMPLETED
Conditions: Lung Cancer|Adenocarcinoma
Interventions: BIOLOGICAL: Phase I - GM.CD40L.CCL21 Vaccinations|BIOLOGICAL: Phase II - GM.CD40L cells Vaccinations|BIOLOGICAL: Phase II - GM.CD40L.CCL21 Vaccinations
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
Status: TERMINATED
Conditions: Coronary Artery Disease
Interventions: OTHER: Remote ischemic preconditioning|OTHER: Sham Remote Ischemic Preconditioning
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: The Role of Oxytocin in Regulating Blood Glucose
Status: RECRUITING
Conditions: Glucose Metabolism Disorders (Including Diabetes Mellitus)
Interventions: DRUG: Oxytocin|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Cognitive Behavioral Therapy for Insomnia (CBTi) in Patients With Somatic Disease
Status: ACTIVE_NOT_RECRUITING
Conditions: Insomnia|Insomnia Chronic|Sleep Initiation and Maintenance Disorders|Sleep Disorder|Sleep Disturbance|Chronic Disease|Insomnia Due to Medical Condition|Insomnia, Psychophysiological
Interventions: BEHAVIORAL: Cognitive behavioral therapy for insomnia (CBTi)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety
Status: TERMINATED
Conditions: Anxiety
Interventions: DEVICE: CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM|DRUG: MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY|OTHER: NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide
Status: UNKNOWN
Conditions: Large-B-cell Diffuse Lymphoma|Chronic Lymphoid Leukemia
Interventions: DRUG: Rituximab|DRUG: Chemotherapy|DRUG: Tenofovir alafenamide
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Status: NOT_YET_RECRUITING
Conditions: Aortic Aneurysm
Interventions: DEVICE: Physician-modified aortic endograft
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy
Status: UNKNOWN
Conditions: Helicobacter Pylori Infection
Interventions: DRUG: PPI quadruple therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
Status: TERMINATED
Conditions: Complex Regional Pain Syndrome, Type I
Interventions: DRUG: lenalidomide|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State
Status: COMPLETED
Conditions: Systemic Lupus Erythematosus (SLE)
Interventions: DRUG: Elsubrutinib|DRUG: Placebo for Elsubrutinib|DRUG: Upadacitinib|DRUG: Placebo for Upadacitinib
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT